The global biologics market size was valued at US$328.617 billion in 2020 and is anticipated to increase at a CAGR of 12.19% over the predictive period to reach US$735.219 billion by 2027.

The global biologics market, during the forecast period, will register growth at a CAGR of 6.95%.The market for biologics is set to reach USD 285,520.4 million by 2023. As per market analysts, the global market is anticipated to witness growth owing to th...

They are widely used for providing effective treatment for several complex diseases, including Crohn’s disease, psoriasis, and rheumatoid arthritis, which have limited options for treatment.

Based on product, the global biologics market is segmented into gene therapy, growth factors, vaccines, interleukins, monoclonal antibody, and others. Of these, the monoclonal antibody segment will have the largest share in the market during the forecast...

The global biologics market is anticipated to touch USD 285,520.4 million at a 6.95% CAGR between 2018-2023, states the new Market Research Future (MRFR) report. Biologics, simply put, are made from materials that come from various living organisms such a...

Companies in the biologics market are spread across the world. The biologics market report provides major information about regional markets of North America, Europe, Asia-Pacific (APAC), and the rest of the world